TRIBIK Drug Use Surveillance

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080223795

Enrollment

600

Registered

2018-02-02

Start date

2018-03-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diphtheria, Pertussis, Tetanus

Interventions

investigational material(s) Generic name etc : TRIBIK(Adsorbed Diphtheria-purified Pertussis-tetanus Combined Vaccine) INN of investigational material : - Therapeutic category code : 636 Mixed biologi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Vaccinees who meet both of the following conditions [1] and [2]: [1] Vaccinees who received TRIBIK at the age of 90 months and over. [2] Vaccinees who are able to participate in a questionnaire survey on the health status after vaccination with TRIBIK ( or vaccinees whose guardians are able to participate in the questionnaire survey).

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
safety safety:Rate of vaccine-related adverse event, Factors that may influence safety, Rate of serious vaccine-related adverse event	—

Secondary

Measure	Time frame
other -	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026